Valuation: Alpha IVF Group

Market Cap 1.28B 314M 279M 260M 237M 447M 30.16B 451M 3.15B 1.22B 15.42B 1.18B 1.15B 49.49B P/E 2026
22.7x
P/E 2027 * 19.6x
Enterprise Value 1.28B 314M 279M 260M 237M 447M 30.16B 451M 3.15B 1.22B 15.42B 1.18B 1.15B 49.49B EV / Sales 2026
6.09x
EV / Sales 2027 * 5.25x
Free-Float
23.4%
Yield 2026
4%
Yield 2027 * 4.15%
1 day+3.92%
1 week+8.16%
Current month+6.00%
1 month+1.92%
3 months+8.16%
6 months+3.92%
Current year-10.17%
1 week 0.24
Extreme 0.24
0.26
1 month 0.24
Extreme 0.235
0.26
Current year 0.24
Extreme 0.235
0.31
1 year 0.24
Extreme 0.235
0.34
3 years 0.24
Extreme 0.235
0.38
5 years 0.24
Extreme 0.235
0.38
10 years 0.24
Extreme 0.235
0.38
Date Insider Type Main position Quantity % Market Cap. Importance
30/04/26 Free

Chief Executive Officer

500,000 0.0103%
18/03/26 Others

Chief Executive Officer

1,555,200,000 32.0000%
18/03/26 Others

Chief Executive Officer

1,555,200,000 32.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+3.92%+8.16%-20.90% - 314M
+0.35%-2.99%+24.73%+32.07% 242B
+1.09%-4.65%+1.77%+0.15% 150B
-2.32%-3.27%-11.53%+32.87% 138B
-1.46%-3.01%-55.73%-19.33% 61.74B
-0.05%-1.32%+11.09%+23.08% 49.08B
+0.66%+0.19%-19.29%-21.24% 47.43B
+0.66%-2.90%+20.97%+51.29% 47.3B
-3.05%-2.62%-9.13%+35.86% 44.25B
-0.08%-1.92%+32.09%+57.18% 41.78B
Average +0.23%-1.44%-2.59%+21.33% 82.3B
Weighted average by Cap. +0.15%-3.27%+3.37%+21.48%

Financials

2026 2027 *
Net sales 202M 49.49M 43.98M 41.04M 37.41M 70.56M 4.76B 71.21M 497M 192M 2.43B 186M 182M 7.81B 244M 59.76M 53.1M 49.56M 45.17M 85.19M 5.75B 85.99M 600M 232M 2.94B 224M 220M 9.43B
Net income 53.6M 13.12M 11.66M 10.88M 9.92M 18.7M 1.26B 18.88M 132M 51.02M 645M 49.26M 48.19M 2.07B 65.5M 16.03M 14.25M 13.3M 12.12M 22.86M 1.54B 23.07M 161M 62.35M 788M 60.2M 58.89M 2.53B
Net Debt - -
Logo Alpha IVF Group
Alpha IVF Group Bhd is a Malaysia-based fertility science, research, and advancement company. The company engages in the provision of assisted reproductive services through its specialist fertility care centers. The company offers access to comprehensive fertility services, technology, and labs across its fertility centers. Its assisted reproductive technologies (ART) refer to a range of medical technologies and treatments complemented with laboratory technologies and procedures to assist individuals or couples in overcoming the challenges of infertility. The company’s assisted reproductive services (ARS) include support services, such as fertility assessment, diagnostics and testing, monitoring, preconception care, and counseling. The medical technologies and treatments of ART are primarily carried out by medical specialists in obstetrics and gynecology, who are also responsible for the prescription of fertility and other related drugs.
Employees
-
Date Price Change Volume
02/10/26 MYR 0.2650 +3.92% 2,377,700
01/10/26 MYR 0.2550 +2.00% 895,700
30/09/26 MYR 0.2500 -1.96% 895,600
29/09/26 MYR 0.2550 +2.00% 2,039,400
28/09/26 MYR 0.2500 +2.04% 1,539,300
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2650MYR
Average target price
0.3300MYR
Spread / Average Target
+24.53%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 0303 Stock